Navigation Links
Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol

PALO ALTO, Calif., Feb. 24 /PRNewswire/ -- Today, Genencor, a division of Danisco A/S, launched Accellerase(R) 1500, the next generation of its cellulosic ethanol enzyme product. Genencor introduced the product at the Renewable Fuels Association (RFA) 2009 National Ethanol Conference in San Antonio, TX.

Accellerase(R) 1500 is another significant step toward commercialization of biofuels and other biochemicals made from cellulosic feedstocks, such as agricultural residues and bioenergy crops. It also reinforces Genencor's position as a global leader in 2nd generation ethanol innovation.

"We're on course to fast-track commercialization of cellulosic ethanol," says Philippe Lavielle, Senior Vice President, Business Development, Genencor. "Accellerase was a breakthrough in the industry. Now, by launching this improved enzyme product, we reach another important technical milestone toward commercial-scale production of transportation fuel and other biochemicals from renewable, non-food feedstocks."

Accellerase(R) 1500 will lower one of the major cost hurdles to producing ethanol or biochemicals from cellulosic feedstocks, such as corn stover, sugarcane bagasse, wood chips, wheat straw, and switchgrass. In addition, Accellerase(R) 1500 has a significantly improved formulation and higher activity resulting in higher ethanol yields and robust operation in a wider variety of processes. The product is based on Genencor's patented gene expression technology and the division's 25-year history of biofuels research.

Accellerase(R) is critical to the hydrolysis step of converting biomass to ethanol or other biochemicals. In this step, plant material is broken down into sugars for fermentation to ethanol.

Genencor supplies Accellerase(R) as part of its dual-strategy to drive forward the cellulosic ethanol industry, which includes its dedicated enzyme business, and its joint venture DuPont Danisco Cellulosic Ethanol LLC (DDCE), which develops and provides integrated technology packages for biomass ethanol production.

Genencor, a division of Danisco A/S, is a world leader in industrial biotechnology and a pioneer in enzyme innovation. Genencor improves process and product performance for a spectrum of industries, from biofuels and laundry detergents to animal nutrition and food. As part of a large global organization, Genencor has a manufacturing and distribution network that spans more than 40 countries. In collaboration with customers, technology leaders and other stakeholders, Genencor supplies competitive, biobased solutions. These innovations create value throughout the supply chain, from raw material to finished product.

SOURCE Genencor
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont and Genencor Create World-Leading Cellulosic Ethanol Company
2. Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol
3. Genencor Appoints New Executive Vice President - Technical Enzymes
4. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
5. EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention
6. Smith & Nephew Launches VISIONAIRE(TM) Patient Matched Technology for Total Knee Replacement
7. CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas
8. Launches a New Season of Industry Career Fairs
9. Millipore Launches an Interactive Biological Pathway Tool Using GeneGos Manually Curated Pathway Maps
10. Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial
11. Cephalons New Product Launches Pace Record 2008 Sales
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
Breaking Biology Technology:
(Date:11/9/2015)... 2015 ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):